Lifecore Biomedical Inc. (LFCR) — Strategic Asset Allocation Index
Lifecore Biomedical Inc. (LFCR) has a Strategic Asset Allocation Index of 353.1% as of May 2023. Strategic assets (PP&E of $120.80 Million plus long-term investments of $-) total $120.80 Million, measured against net assets of $34.21 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Lifecore Biomedical Inc. Strategic Asset Allocation Index (2019–2023)
This chart shows how Lifecore Biomedical Inc.'s Strategic Asset Allocation Index has evolved across 5 annual periods from 2019 to 2023. As of May 2023, the index stands at 353.1%, representing strategic assets of $120.80 Million against net assets of $34.21 Million USD. Explore how efficiently does Lifecore Biomedical Inc. generate cash to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Lifecore Biomedical Inc. (2019–2023)
The table below presents the year-by-year Strategic Asset Allocation Index for Lifecore Biomedical Inc. from 2019 to 2023, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see how much is Lifecore Biomedical Inc. worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 153.3% | $134.59 Million | $134.59 Million | $- | $87.82 Million | ▲ +24.5 pp |
| 2022 | 128.8% | $139.01 Million | $139.01 Million | $- | $107.94 Million | ▲ +38.8 pp |
| 2021 | 90.0% | $182.48 Million | $137.38 Million | $45.10 Million | $202.78 Million | ▼ -28.8 pp |
| 2020 | 118.8% | $274.56 Million | $217.66 Million | $56.90 Million | $231.04 Million | ▲ +22.2 pp |
| 2019 | 96.7% | $261.13 Million | $200.03 Million | $61.10 Million | $270.14 Million | — |